Theralase Technologies Inc. V.TLT

Visibility

[DJDawg]

I've read that many biotech type investors read the abstract and poster announcements to get a sense of what companies might be presenting new and good trial information. These are the first conferences that TLT has done in years so two chances to get some new buyers in the pipeline. Might take days or weeks for it to build as they do some DD but that would be cool if true.

[ScienceFirst]

It's more a question of gaining visibility, assessing interest, etc ...  If the FDA designation comes before the AUA congress, that will be quite amazing in terms of marketing. We now have a finished "product" (treatment).  We are no more just a R&D biotech.  We're now aiming to market our treatment once we have regulatory authorization.  Accelerated